Clinical Drug Experience Knowledgebase

inactivated SARS-Cov-2 vaccine (2 trials)

meningococcal conjugate vaccine (Menveo) (3 trials)

sars-cov-2 ad5 (2 trials)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (3 trials)

acyw135 mcv (1 trial)

ad5-ncov (13 trials)

bivalent recombinant covid-19 vaccine (adenovirus type 5 vector) (1 trial)

bnt162b2 (Comirnaty) (2 trials)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix) (1 trial)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (1 trial)

Monovalent group A meningococcal vaccine (Menomune-A) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)

tetanus toxoid (3 trials)

covid-19 mrna vaccine (2 trials)

ebola vaccine (Ervebo) (1 trial)

recombinant novel coronavirus vaccine (adenovirus type 5 vector) (1 trial)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)

ad5-ebov (3 trials)

chadox1-vzv (1 trial)

diphtheria, tetanus, and poliovirus vaccine (1 trial)

diphtheria toxoid (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

Inactivated polio virus - Enhanced (IPOL) (1 trial)

pbpv (1 trial)

Protein Based Pneumococcal Vaccine (1 trial)

sf-rvn (1 trial)

sodium chloride (1 trial)

varicella zoster virus glycoprotein e antigen (Shingrix) (1 trial)

vlp-polio (1 trial)